First Time Loading...

CareDx Inc
NASDAQ:CDNA

Watchlist Manager
CareDx Inc Logo
CareDx Inc
NASDAQ:CDNA
Watchlist
Price: 15.34 USD 3.79% Market Closed
Updated: May 18, 2024
Financials Section:
Income Statement Balance Sheet Cash Flow Statement
|
Revenue Breakdown

Balance Sheet

466.8m
-7%
Assets
Growth Rates:
1 Year
-14%
3 Years
+27%
5 Years
+257%
7 Years
+509%
10 Years
+4 615%
205.5m
+92%
Liabilities
Growth Rates:
1 Year
+83%
3 Years
+126%
5 Years
+491%
7 Years
+259%
10 Years
+712%
261.3m
-34%
Equity
Growth Rates:
1 Year
-39%
3 Years
-6%
5 Years
+173%
7 Years
+1 240%
10 Years
-

Balance Sheet Decomposition
CareDx Inc

466.8m
Assets
205.5m
Liabilities
466.8m
Assets
205.5m
Liabilities
Current Assets 313.7m
Cash & Short-Term Investments 235.4m
Receivables 51.1m
Other Current Assets 27.2m
Non-Current Assets 153.1m
PP&E 65.1m
Intangibles 86m
Other Non-Current Assets 1.9m
Current Liabilities 78.1m
Accounts Payable 12.9m
Accrued Liabilities 35.4m
Other Current Liabilities 29.8m
Non-Current Liabilities 127.4m
Other Non-Current Liabilities 127.4m

Balance Sheet
CareDx Inc

Rotate your device to view
Balance Sheet
Currency: USD
Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023
Assets
Cash & Cash Equivalents
36
30
17
17
65
38
135
349
90
82
Cash Equivalents
36
30
17
17
65
38
135
349
90
82
Short-Term Investments
0
0
0
0
0
0
90
0
203
153
Total Receivables
3
2
3
3
10
24
35
60
66
51
Accounts Receivables
3
2
3
3
10
24
35
60
66
51
Other Receivables
0
0
0
0
0
0
0
0
0
0
Inventory
1
1
6
6
5
6
10
17
19
19
Other Current Assets
1
1
1
1
2
4
4
8
9
8
Total Current Assets
40
34
27
27
81
72
273
433
388
314
PP&E Net
2
2
3
2
4
9
26
40
70
65
PP&E Gross
2
0
0
0
4
9
26
40
70
65
Accumulated Depreciation
11
0
0
0
14
15
17
20
24
32
Intangible Assets
7
7
33
33
33
46
44
50
43
46
Goodwill
12
12
14
12
12
24
24
37
38
40
Other Long-Term Assets
0
0
0
10
0
1
1
6
4
2
Other Assets
12
12
14
12
12
24
24
37
38
40
Total Assets
61
N/A
56
-9%
77
+38%
84
+9%
131
+56%
152
+16%
369
+143%
567
+54%
543
-4%
467
-14%
Liabilities
Accounts Payable
1
2
3
3
5
6
10
13
10
13
Accrued Liabilities
3
6
9
9
11
19
26
44
41
35
Short-Term Debt
0
0
0
0
0
0
0
0
0
0
Current Portion of Long-Term Debt
6
3
23
16
0
0
0
0
0
0
Other Current Liabilities
1
0
6
15
3
11
34
20
25
30
Total Current Liabilities
11
10
41
43
20
35
69
77
76
78
Long-Term Debt
6
13
1
18
0
0
0
0
0
0
Deferred Income Tax
0
0
6
5
3
2
1
0
0
0
Minority Interest
0
0
0
0
0
0
0
0
0
0
Other Liabilities
3
3
9
23
12
16
20
23
36
127
Total Liabilities
20
N/A
26
+32%
57
+119%
90
+57%
35
-61%
53
+51%
91
+72%
101
+11%
112
+11%
205
+83%
Equity
Common Stock
0
0
0
0
0
0
0
0
0
0
Retained Earnings
159
173
213
268
312
334
353
383
460
678
Additional Paid In Capital
201
203
236
264
412
438
632
854
899
947
Other Equity
0
0
4
2
4
5
2
5
8
7
Total Equity
41
N/A
30
-29%
20
-34%
6
N/A
96
N/A
99
+3%
278
+181%
466
+68%
431
-8%
261
-39%
Total Liabilities & Equity
61
N/A
56
-9%
77
+38%
84
+9%
131
+56%
152
+16%
369
+143%
567
+54%
543
-4%
467
-14%
Shares Outstanding
Common Shares Outstanding
12
12
21
29
41
43
49
53
54
52

See Also

Summary
CDNA intrinsic value, competitors valuation, and company profile.
DCF Valuation
CDNA stock valuation using Discount Cash Flow valuation method.
Relative Valuation
CDNA stock valuation using valuation multiples.
Wall Street Estimates
CDNA price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
CDNA stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 138,200+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.